The technology-transfer unit of Imperial College London, continuing preparations for its stock-market debut on 31 July, said it has completed a £25 million private placement and set a public share price that would value the business at £181 million.
The pressing need for alternative energy sources is driving investment into nanotechnology devices for energy applications such as photovoltaic solar cells.
Two companies that began life in laboratories at Cambridge University have merged to form a new medical diagnostics company, to be called Pronostics Ltd.
On Tuesday the UK became the latest country to jump back on the nuclear energy bandwagon. But 20 years after Chernobyl, how easy is it to turn on the nuclear tap?
This week the European Investment Fund took the first step in its ambitious new plan to unleash a wave of technology transfer across Europe. In doing so it endorsed a model pioneered in the UK.
Top materials scientist Eicke Weber has been lured back to Germany from the US after 23 years, to take over at the helm of the Fraunhofer’s Institute of Solar Energy.
French researchers have developed a cell therapy that could slash the risk of rejection after bone marrow grafts to under 5 per cent, and are looking for first-round funding.
The European Investment Fund has partnered with UK technology commercialisation company IP Group to form a venture capital fund to invest in university spin-outs.
For the last three years, the French parliament has been struggling with legislation on copyright and associated rights in information society. It has surfaced in the headlines, portrayed as a fight to force Apple to make its iTunes music downloads playable on competing music boxes. But there's more involved.
A key distinction between physical and intellectual property is that the value of the latter is created as much by sharing it as by owning it. How to share it, between creator and enabler, is a particularly acute issue within the academic environment - as indicated by a recent, noteworthy debate on the subject in Sweden.
The Health Research Board of Ireland is to join the consortium of UK research funders developing a single gateway to the largest pool of patients in the world.
Orla Protein Technologies, a spin-out from the University of Newcastle upon Tyne, UK, is looking to raise £3 million in a series A funding round for the next stage of its development.
Technology transfer is a sensitive and complex process. Changing one factor won’t provide the magic bullet, says Anna S. Nilsson, Science and Technology Attaché at the Swedish Embassy in Washington DC.
Swedish spin-out Denator Biotechnology is raising money to fund development of its technology that analyses protein samples without adulterating them with added reagents.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.